Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Greg Baker / AP
Top Trump administration officials are slated to meet with a number of executives from drug companies and government scientific researchers at the White House on May 8, according to an agenda obtained by Bloomberg. The meeting is described in the memo as a chance for "private sector and thought leaders to describe their institution and its connection to federal funding."
Why it matters: This could give biotech executives a chance to make a direct pitch for the value of federal medical research funding, something they've wanted to do ever since President Trump's budget proposed a nearly 20 percent cut in NIH funding.
Who's coming: Vice President Mike Pence, Ivanka Trump, Jared Kushner, HHS Secretary Tom Price, and NIH Director Francis Collins, among others.
Not mentioned: Office of Management and Budget director Mick Mulvaney, the main advocate of the NIH cuts.